QTTB — Q32 Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $17.56m
- -$35.22m
Annual cashflow statement for Q32 Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -129 | -95.8 | -5 | -113 | -47.7 |
| Depreciation | |||||
| Non-Cash Items | 14.9 | 19.5 | -113 | 23.4 | -10.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.5 | -41.8 | 3.35 | -7.21 | -9.64 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -94.3 | -110 | -114 | -96.2 | -67.7 |
| Capital Expenditures | -3.73 | -2.4 | -1.28 | -0.228 | -0.075 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 209 | -48.4 | 38 | 102 | 20 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 205 | -50.8 | 36.7 | 101 | 19.9 |
| Financing Cash Flow Items | — | — | — | — | 44.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 53.1 | 52.2 | 0.596 | 0.184 | 95.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 164 | -108 | -76.3 | 5.28 | 47.3 |